Yang, H., Sun, P., Liu, P., Wang, Y., Zhou, H., Lu, Y., Zhang, L., Zhou, K., Li, Z. (2025). First-line selinexor plus R-CHOP for high-risk GCB-subtype diffuse large B-cell lymphoma: A multi-center, single-arm, Phase II trial. Blood. https://doi.org/10.1182/blood-2025-1922